RNA Stock Analysis: Buy, Sell, or Hold?
RNA - Avidity Biosciences, Inc. Common Stock
$12.91
-0.03 (-0.23%)
▼
5d:
+1.25%
30d:
-1.0%
90d:
-2.2%
BUY
HIGH Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When RNA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: RNA shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: RNA shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: RNA is currently trading at $12.91, which is considered slightly high relative to its 30-day fair value range of $12.11 to $13.10.
Technical Outlook: Technically, RNA is in a strong uptrend. The price is approaching resistance at $13.14. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: RNA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $25.00 (+93.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, RNA is in a strong uptrend. The price is approaching resistance at $13.14. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: RNA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $25.00 (+93.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$12.11 -
$13.10
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.9%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 93.2% below Wall St target ($25.00)
Trading Range Analysis
30-Day Trading Range
$12.11 -
$13.10
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$11.40
Resistance Level
$13.14
Current Trend
Strong Uptrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.21
Wall Street Target
$25.00
(+93.2%)
Revenue Growth (YoY)
1148.3%
Profit Margin
-160.0%
Share & Embed Analysis
Last updated: June 23, 2026 2:03 PM ET
Data refreshes hourly during market hours. Next update: 3:03 PM
Data refreshes hourly during market hours. Next update: 3:03 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RNA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
13
Sells
Net
INSIDERS SELLING
Recent Transactions
Michael F Maclean
SELL
4542 shares
2026-01-21
Arthur A Levin
SELL
1758 shares
2026-01-21
W. Michael Flanagan
SELL
6534 shares
2026-01-21
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 56 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 57 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 61 BUY |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 54 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 59 HOLD |
Advanced RNA Option Strategies
Professional options setups generated by AI based on today's RNA price and gamma walls.
